These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 30502453

  • 1. The crystalline salt form of a selected candidate drug showed photo-, thermal- and humidity induced form transitions.
    Sigfridsson K, Lindsjö M, Paulsson S.
    Eur J Pharm Sci; 2019 Feb 01; 128():128-136. PubMed ID: 30502453
    [Abstract] [Full Text] [Related]

  • 2. Salt formation improved the properties of a candidate drug during early formulation development.
    Sigfridsson K, Ahlqvist M, Lindsjö M, Paulsson S.
    Eur J Pharm Sci; 2018 Jul 30; 120():162-171. PubMed ID: 29730322
    [Abstract] [Full Text] [Related]

  • 3. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH, Gordon S, Holm R, Selen A, Rades T, Müllertz A.
    Eur J Pharm Biopharm; 2013 Nov 30; 85(3 Pt B):942-51. PubMed ID: 24075980
    [Abstract] [Full Text] [Related]

  • 4. Undesired co-amorphisation of indomethacin and arginine during combined storage at high humidity conditions.
    Petry I, Löbmann K, Grohganz H, Rades T, Leopold CS.
    Int J Pharm; 2018 Jun 10; 544(1):172-180. PubMed ID: 29669257
    [Abstract] [Full Text] [Related]

  • 5. Preformulation investigation and challenges; salt formation, salt disproportionation and hepatic recirculation.
    Sigfridsson K, Nilsson L, Ahlqvist M, Andersson T, Granath AK.
    Eur J Pharm Sci; 2017 Jun 15; 104():262-272. PubMed ID: 28366653
    [Abstract] [Full Text] [Related]

  • 6. Relative humidity-temperature transition boundaries for anhydrous β-caffeine and caffeine hydrate crystalline forms.
    Allan MC, Owens B, Mauer LJ.
    J Food Sci; 2020 Jun 15; 85(6):1815-1826. PubMed ID: 32449950
    [Abstract] [Full Text] [Related]

  • 7. Stability of polymorphic forms of ranitidine hydrochloride.
    Wu V, Rades T, Saville DJ.
    Pharmazie; 2000 Jul 15; 55(7):508-12. PubMed ID: 10944778
    [Abstract] [Full Text] [Related]

  • 8. Mapping the solid-state properties of crystalline lysozyme during pharmaceutical unit-operations.
    Mohammad MA, Grimsey IM, Forbes RT.
    J Pharm Biomed Anal; 2015 Oct 10; 114():176-83. PubMed ID: 26068908
    [Abstract] [Full Text] [Related]

  • 9. Preformulation evaluation of AZD1305, an oxabispidine intended for oral and intravenous treatment.
    Sigfridsson K, Lundqvist R, Ohlson K.
    Drug Dev Ind Pharm; 2012 Jan 10; 38(1):19-31. PubMed ID: 21707325
    [Abstract] [Full Text] [Related]

  • 10. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
    McNamara D, Yin S, Pan D, Crull G, Timmins P, Vig B.
    Mol Pharm; 2017 Feb 06; 14(2):377-385. PubMed ID: 28068097
    [Abstract] [Full Text] [Related]

  • 11. A preformulation evaluation of a photosensitive surface active compound, explaining concentration dependent degradation.
    Sigfridsson K, Carlsson KE.
    Eur J Pharm Sci; 2017 Nov 15; 109():650-656. PubMed ID: 28736127
    [Abstract] [Full Text] [Related]

  • 12. Investigation of recrystallization of amorphous trehalose through hot-humidity stage X-ray powder diffraction.
    Jójárt-Laczkovich O, Katona G, Aigner Z, Szabó-Révész P.
    Eur J Pharm Sci; 2016 Dec 01; 95():145-151. PubMed ID: 27496047
    [Abstract] [Full Text] [Related]

  • 13. Crystal forms of the hydrogen oxalate salt of o-desmethylvenlafaxine.
    Dichiarante E, Curzi M, Giaffreda SL, Grepioni F, Maini L, Braga D.
    J Pharm Pharmacol; 2015 Jun 01; 67(6):823-9. PubMed ID: 25644936
    [Abstract] [Full Text] [Related]

  • 14. Selection of optimal hydrate/solvate forms of a fibrinogen receptor antagonist for solid dosage development.
    Bray ML, Jahansouz H, Kaufman MJ.
    Pharm Dev Technol; 1999 Jan 01; 4(1):81-7. PubMed ID: 10027216
    [Abstract] [Full Text] [Related]

  • 15. Influence of pH and method of crystallization on the solid physical form of indomethacin.
    Dubbini A, Censi R, Martena V, Hoti E, Ricciutelli M, Malaj L, Di Martino P.
    Int J Pharm; 2014 Oct 01; 473(1-2):536-44. PubMed ID: 25064728
    [Abstract] [Full Text] [Related]

  • 16. Physical characterization of nedocromil sodium hydrates.
    Khankari R, Chen L, Grant DJ.
    J Pharm Sci; 1998 Sep 01; 87(9):1052-61. PubMed ID: 9724554
    [Abstract] [Full Text] [Related]

  • 17. Solid state characterization of dehydroepiandrosterone.
    Chang LC, Caira MR, Guillory JK.
    J Pharm Sci; 1995 Oct 01; 84(10):1169-79. PubMed ID: 8801330
    [Abstract] [Full Text] [Related]

  • 18. Moisture sorption behavior of selected bulking agents used in lyophilized products.
    Fakes MG, Dali MV, Haby TA, Morris KR, Varia SA, Serajuddin AT.
    PDA J Pharm Sci Technol; 2000 Oct 01; 54(2):144-9. PubMed ID: 10822985
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Thermodynamic stability considerations for isostructural dehydrates.
    Murphy BJ, Casteel MJ, Samas B, Krzyzaniak JF.
    J Pharm Sci; 2012 Apr 01; 101(4):1486-95. PubMed ID: 22262468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.